PDS Biotechnology Corporation - Common Stock (PDSB)
1.4300
+0.1000 (7.52%)
NASDAQ· Last Trade: May 14th, 7:30 PM EDT
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · March 14, 2025

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · March 12, 2025

NEW YORK, NY / ACCESSWIRE / December 5, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued a new C-Level interview with PDS Biotechnology Corporation.
Via ACCESSWIRE · December 5, 2022
Global Cervical Cancer Treatment Market Size Expected to Reach $11 Billion By 2027
Palm Beach, FL – October 6, 2022 – FinancialNewsMedia.com News Commentary – The global Cervical Cancer Treatment market has been expanding for several years and is projected to continue at a growing CAGR. Cervical Cancer is a cancer arising from the cervix which is due to the abnormal growth of cells that have the ability […]
Via FinancialNewsMedia · October 6, 2022